Skip to main content

US, Pfizer reach $3.2B COVID vaccine deal

Partners Pfizer and BioNTech SE said they had signed a more than $3-billion-dollar agreement with the U.S. government for 105 million doses of their COVID vaccine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.